AAFA CEO shares concern about allergy shot restrictions at AAAAI16
AAFA's CEO Dr. Cary Sennett spoke on a panel at AAAAI in March to share patient concerns about proposed guideline changes recently made by the U.S. Pharmacopeial Convention (USP) which could limit patient access to allergen immunotherapy (allergy shots).
Comments (0)